Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms
- 1 December 2018
- journal article
- review article
- Published by Elsevier BV in Cancer Genetics
- Vol. 228-229, 197-217
- https://doi.org/10.1016/j.cancergen.2018.07.003
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidineBlood Cancer Journal, 2013
- SNP array analysis in hematologic malignancies: avoiding false discoveriesBlood, 2010
- FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q)Leukemia Research, 2010
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignanciesBlood, 2010
- Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome‐wide single nucleotide polymorphism array analysisGenes, Chromosomes and Cancer, 2010
- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasmsBlood, 2009
- Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogeneticsLeukemia, 2009
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid MalignanciesCancer Research, 2008
- Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AMLBlood, 2008
- High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArraysGenome Research, 2007